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Abstract
Background: Mycobacteria have a spectrum of virulence and different susceptibilities to antibiotics. Distinguishing
mycobacterial species is vital as patients with non-tuberculous mycobacterial (NTM) infections present clinical
features that are similar to those of patients with tuberculosis. Thus, rapid differentiation of Mycobacterium
tuberculosis complex from NTM is critical to administer appropriate treatment. Hence the aim of the study was to
rapid identification of mycobacterial species present in bronchial washings using multiplex real time Polymerase
Chain Reaction (PCR) and to determine the drug susceptibility in identified mycobacterial species.
Methods: Sputum smear negative bronchoscopy specimens (n = 150) were collected for a period of one year, from
patients attending the General Hospital Kandy, Sri Lanka. The specimens were processed with modified Petroff’s
method and were cultured on Löwenstein– Jensen medium. DNA, extracted from the mycobacterial isolates were
subjected to a SYBR green mediated real time multiplex, PCR assay with primers specific for the M. tuberculosis
complex, M. avium complex, M. chelonae-M.abscessus group and M. fortuitum group. DNA sequencing was
performed for the species confirmation, by targeting the 16S rRNA gene and the drug susceptibility testing was
performed for the molecularly identified isolates of M. tuberculosis and NTM.
Results: The optimized SYBR Green mediated multiplex real-time PCR assay was able to identify the presence of
genus Mycobacterium in 25 out of 26 AFB positive isolates, two M. tuberculosis complex, three M. avium complex
and two isolates belonging to M. chelonae-M. abscessus group. DNA sequencing confirmed the presence of M.
tuberculosis, M. chelonae-M. abscessus, M. intracellulare, M. avium, Rhodococcus sp. and M. celatum. Remaining isolates
were identified as Mycobacterium sp. All the NTM isolates were sensitive to amikacin and seven were resistant to
ciproflaxacin. Twenty two of the NTM isolates and the isolate Rhodococcus was resistant to clarithromycin. The two
isolates of M. tuberculosis were sensitive to all first line anti tuberculosis drugs.
Conclusion: The optimized SYBR Green mediated multiplex real time PCR assay could be an effective tool for the
rapid differentiation of pathogenic M. tuberculosis complex from the opportunistic nontuberculous mycobacteria
and also it confirmed the presence of NTM in 15.3 % of the study population.
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Background
Tuberculosis (TB) is an infectious disease caused by
strains of Mycobacterium tuberculosis complex (MTC)
which is currently one of the leading causes of death in
the world [1]. Alternatively, pulmonary infections caused
by non-tuberculous mycobacteria (NTM), i.e. Mycobacter-
ium species that are not members of MTC are also in the
rise [2]. The increasing prevalence of the multi-drug re-
sistant (MDR) TB strains are an added intimidation to the
global TB burden, due to their resistance to the most
effective first line anti-tuberculous drugs rifampin (RIF)
and isoniazid (INH) [3]. The incidence of demises due
to NTM related pulmonary infections have increased
globally [4] and the rapid increase in the incidence of
NTM disease in AIDS patients have also been recorded.
Mycobacteria can be broadly classified as rapid growers
(<7 days) and slow growers (>7 days) [5]. Fast growers
commonly have two identical copies of the 16S rRNA
gene, whereas slow growers have only one single copy
[6]. When a case of mycobacterial infection is detected,
both the clinical and public health management depend
critically on whether the causative agent is a MTC or a
NTM to prevent clinical misleading during therapeutic
actions, as patients with NTM infections show clinical
signs that are similar to those of patients with TB [7].
Mycobacteria have a spectrum of virulence and differ-
ent susceptibilities to antibiotics and it is believed that
altered target proteins produced due to specific gene al-
terations such as mutations, insertions or deletions are
influencing the degree of susceptibility to the drug [8].
Though it is anticipated that the patient’s symptoms are
mainly due to M. tuberculosis (MTB), the role of co-
infecting NTM species in the pathogenesis of the pul-
monary disease is still unclear. The presence of NTM
in the patients with chronic TB has a substantial impact
on clinical management. The treatment of diseases with
MTC and NTM are different because many of the first
and second line anti-tuberculous drugs are ineffective
against many NTM [2]. Incorrect diagnosis of pulmonary
diseases, i.e. if priority is given only for MTC and avoiding
the presence of NTM, will lead to inappropriate treat-
ments and the patients will not respond to conventional
therapy [9].
As conventional detection methods such as, biochemical
tests consume time [2], currently DNA amplification using
Polymerase Chain Reaction (PCR) has allowed great pro-
gress in the rapid and accurate diagnosis of mycobacterial
infections. Innovations in real –time PCR technology have
eased and advanced the PCR methodology extensively.
Application of SYBR green mediated real time PCR assay
in clinical microbiology had improved the diagnostics due
to the increased specificity and the ability to detect two or
more organisms in a single reaction [10]. Rapid availability
of the results is an added advantage of SYBR green
mediated real time PCR assay over conventional PCR.
Rapid identification will assist in avoiding unnecessary
drug exposure and could aid in reducing the mortality
and morbidity.
Incidence of TB in Sri Lanka was 66 in 2013. Human
immunodeficiency virus (HIV) testing of all TB patients
was made mandatory in the country since 2013. In 2013,
4646 TB patients were screened for HIV and out of
these patients, six were found positive. In addition, there
were nine patients with known HIV status at the time of
diagnosis of TB, contributing to a total of 15 patients
with HIV/ TB co-infection in 2013 [11]. In Sri Lanka,
highest priority is given for the definitive diagnosis of
TB and due to the limited records [12] about the NTM
in clinical specimens, no testing is carried out for defini-
tive diagnosis of NTM infections. Therefore any person
with symptoms suggestive of TB, particularly cough for
more than three weeks are being investigated only for
TB and similar to other developing countries, routine
diagnosis of TB in Sri Lanka is done with the sputum
microscopy which could lead to the misdiagnosis of the
pulmonary disease.
In our previous study we demonstrated the usefulness
of bronchial washings as the preferred specimen in diag-
nosis of NTM lung disease by culture as well as from
molecular techniques and about 13 to 14 % of the study
population had NTM in their bronchial washings [12].
Hence in this study we assessed the utility of SYBR
green mediated multiplex, real time PCR for the rapid
identification of Mycobacterium species present in bron-
chial washings and also determined the drug sensitivity
patterns of the identified mycobacterial isolates.
Methods
Study setting, population and ethics
Sputum smear negative bronchoscopy specimens were
collected from patients (n = 150) attending the General
Hospital Kandy, Sri Lanka from January 2014 to March
2015 who had pulmonary symptoms, nodular or cavitary
opacities on chest radiograph, or an HRCT scan that
showed multifocal bronchiectasis with multiple small nod-
ules. Approval for the study was obtained from the Ethical
Review Committee of the Postgraduate Institute of Science,
University of Peradeniya, Sri Lanka. The bronchoalvelar
lavage (BAL) specimens were collected as a part of routine
investigations and a portion of the specimens were used
for culturing. Written informed consent was obtained from
each patient before bronchoscope and collecting the BAL
specimens.
Laboratory analysis
Sample processing, culture and DNA extraction
The samples were liquefied and decontaminated with
4 % NaOH according to the modified Petroff ’s method
Keerthirathne et al. BMC Infectious Diseases  (2016) 16:607 Page 2 of 8
[13]. The decontaminated specimens were inoculated
onto Löwenstein–Jensen media (L-J media), LJ media
containing Thiophene – 2 carboxylic acid hydrazide
(TCH) and p-nitrobenzioc acid (PNB) and cultures were
observed for 8 to 12 weeks incubating at 37 °C and at
28 °C in light and dark conditions. Solid medium slants
were considered positive when visible colonies grew.
The colonies were further confirmed as mycobacteria by
the Ziehl–Neelsen stain. All cultures that showed myco-
bacterial growth were subjected to further analysis.
Genomic DNA was extracted from the mycobacterial
isolates according to the standard CTAB (N-Cetyl-N,
N, N-trimethyl ammonium bromide) method [14].
Real - time multiplex PCR analysis
PCR primers targeting the internal transcribed spacers
(ITSs) of MTC and M. chelonae-M. abscessus group
(MCAG), the 16S rRNA genes of M. avium complex
(MAC), M. fortuitum group (MFG) and the region of
the 16SrRNA gene common to all the members of genus
Mycobacterium which were described previously [10]
were used for the optimizing of real -time multiplex,
PCR assays (Table 1). The assays were performed on a
real time PCR Instrument System (Rotor-GeneQ) and
the DNA amplifications were monitored by the meas-
urement of the SYBR Green fluorescence. The real time
multiplex PCR assay was conducted in two separate re-
actions where primers specific for MTC and MAC were
in reaction I and primers specific for MCAG and MFG
were in reaction II which helped in identifying slow and
rapid growers respectively. Primers targeting genus
Mycobacterium were included in both the reactions
(Table 1). Each reaction was carried out in a 25 μl volume
which contained 2.0 μl of 25 mM MgCl2, 0.25 μl of 5 u /μl
Taq polymerase, 5.0 μl of 5X PCR Buffer, 2.5 μl of 1 mM
dNTP mix, 1.0 μl of each primer (10 μm), 1.25 μl of 2X
SYBR green and 50 ng of the extracted mycobacterial
DNA. The PCR amplification process was initiated by
ramping the temperature at 95 °C for 5 min followed by
40 cycles of the amplification process (95 °C for 15 s,
60 °C for 30s and 72 °C for 30s). Subsequent to the cyc-
ling process, melting curves were generated by inclining
the temperature from 60 °C to 95 °C at 0.2 °C/s.
DNA sequencing for species confirmation
For the species confirmation, the extracted DNA of the
mycobacterial isolates were subjected to amplification of
the 16S rRNA gene with the use of universal primers, F:
5’ TGGAGAGTTTGATCCTGGCTCAG 3’ and R: 5’
AAGGAGGTGATCCATC 3’ [10]. The amplified DNA
was visualized from gel documentation system (SYNGENE)
after the electrophoresis in 1.5 % agarose and ethidium
bromide staining. 1kbp DNA marker was used to identify
correct fragment of 1.5kbp. Amplified DNA fragments were
purified using gel extraction kit (Promega) and were com-
mercially sequenced from Macrogen Inc., South Korea
using ABI 3730XL sequencers. The sequence data obtained
were analysed using the software program BioEdit 7.0.9.
The results were compared with the sequences from the
GenBank database and the obtained sequences were depos-
ited in the GeneBank database.
Drug susceptibility analysis
The drug susceptibility testing for both MTC (n = 2) and
NTM (n = 22) were carried out in duplicate with freshly
grown cultures using the methods of agar proportion
and the disk diffusion [15]. Susceptibility to isoniazid
(INH) (0.2 μg/ml, 1.0 μg/ml), rifampin (RIF) (0.2 μg/ml),
streptomycin (2 μg/ml, 10 μg/ml), ethambutol (5.0 μg/
ml,10 μg/ml) and pyrazinamide (25 μg/ml) were deter-
mined with the agar proportion method [16] performed
on Middle Brook 7H11 (MB7H11) agar media enriched
with the oleic albumin dextrose catalase (OADC) supple-
ment. The standard strain of H37Rv was used as the posi-
tive control. MB7H11 agar plates of 4–5 mm thickness,
enriched with the OADC supplement was used for the
susceptibility testing of the drugs amikacin (30 μg), cipro-
floxacin (5 μg) and clarithromycin (15 μg) incorporated
disks, purchased commercially from Hardy Diagnostics,
Santa Maria, CA. At the same time, the viability of the
disks were tested using the control strains of Escherichia
coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853
and Staphylococcus aureus ATCC 25923 on Mueller-
Hinton Agar medium. Susceptibility patterns of these
organisms were compared as stated in Clinical and
Table 1 Primers used for SYBR Green mediated, multiplex real-
time PCR assay [10]
Organism Target
region












ITS F: GCGAGAGCCGGGTGCATG I
R: AACAGTGTGTTGGTGGCCAA
AFB genus 16S F: CCGCAAGRCTAAAACTCAAA I/II
R:
TGCACACAGGCCACAAGGGA
MCAG ITS F: TAAGGAGCACCATTTCCCAG II
R: CGACGTTTTGCCGACTACC
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Laboratory Standards Institute standard operating pro-
cedures [14].
Results
Participants and the culture characteristics
Of the 150 patients included in the study, 93 were males.
The men: women ratio was 1.6:1. The age range was 12
to 83 years. 32 % of the males were above the age of
60 years while in females only 11 % were above the age
of 60 years. But in the age group of 15–60 years, female
percentage was higher (32 %) in comparison to the male
patients (24 %). Of the 150 specimens, 52 had a growth
within eight weeks of incubation. Overall, twenty three
of 150 patients (15.3 %) were positive for any Mycobac-
terium species by culture (by confirmation of AFB). Out
of these 23 patients, 14 were females (60.8 %) and MTB
was identified in two of them. When mycobacterial culture
was considered as the gold standard there were 26 isolates
(17.3 %) from 23 patients belonging to the Mycobacterium
genus and among theses 23 (15.3 %) were NTM. All the
mycobacterial cultures were rapid growers except for two
isolates. Mixed growths were observed from the two
bronchial wash specimens. The sample KCC2 yielded three
different isolates (02RC, 02YC and 02WC) and the sample
KCC 6 yielded two isolates (06 RC and 06PL) and all these
culture isolates were confirmed as AFB positive by ZN
staining.
Analysis of SYBR green mediated real time multiplex PCR
assay
Initial assessment of the PCR primers for the specificity
and the sensitivity of the genus Mycobacterium and
MTC was done in a single–plex real time PCR with a
standard H37Rv strain, an isolate of M. intracellulare
and M. phocaicum, and a collection of previously identi-
fied clinical isolates of MTB. The presence of the ampli-
con was detected by the fluorescent dye SYBR green and
the species specificities were defined by the analysis of
melting curves. In Reaction 1, a DNA template from MTB
produced a peak with a Tm ~ 77 °C, which corresponded
to MTC, and a peak with a Tm ~ 80–83 °C which corre-
sponded to the genus Mycobacterium respectively. Simi-
larly DNA from MAC produced a peak with a Tm ~ 85 °C,
which corresponded to MAC (Fig. 1a). In Reaction II, a
DNA template from MCAG produced a peak with a Tm ~
77 °C, which corresponded to MCAG, and a peak with a
Tm ~ 80–83 °C corresponded to the genus Mycobacterium
respectively. Similarly in Reaction II, DNA from Mycobac-
terium spp. produced peaks with Tm ~ 84–89 °C, which
corresponded to MFG and other mycobacteria and a peak
with a Tm ~ 80–83 °C which corresponded to the genus
Mycobacterium (Fig. 1b). When the mycobacterial DNA
of the study population were subjected to Reaction I of
the SYBR green mediated real time multiplex PCR assay,
it confirmed the presence of Mycobacterium genus in
25 of the 26 AFB positive isolates, in two MTC (n = 2)
isolates and three MAC (n = 3) isolates. Evaluation of
the analysis of Reaction II also confirmed the presence
of genus Mycobacterium in tested mycobacterial isolates
and also the presence of MCAG in two isolates (n = 2).
Analysis of DNA sequencing
DNA sequencing confirmed the presence of a Rhodococ-
cus sp. (n = 1), a Mycobacterium celatum (n = 1), M. chelo-
nae-abscessus complex (n = 3), two isolates were identified
as M. intracellulare and the other isolate as M. avium.
The isolates identified as MTC were confirmed as MTB
and the remaining isolates could be only identified as be-
longing to genus Mycobacterium.
Analysis of drug susceptibility testing
All the NTM isolates were sensitive to amikacin and
seven were resistant to ciproflaxacin. Except for the two
isolates of M. chelonae-abscessus complex and a single
isolate of M. intracellulare, all the other isolates of NTM
were resistant to clarithromycin (Table 2). None of the
isolates were resistant to all three tested drugs. The two
isolates of M. tuberculosis were sensitive to all first line
anti tuberculosis drugs.
Discussion
Conclusive diagnosis of a mycobacterial infection com-
monly involves isolation and identification of the infect-
ing organism in the laboratory by culture, even though,
the preliminary diagnosis is frequently based on clinical
data [17]. But even when cultures are detected positive
and the presence of mycobacteria were confirmed by ZN
staining it is not yet possible to confirm it as a MTC or
a NTM [18]. To address this issue we have optimized a
molecular assay capable of identifying MTC and NTM
when applied to positive cultures on LJ; further identifica-
tion of species is achieved by the sequencing of 16SrDNA
sequencing. In this study, 25 clinical isolates were identi-
fied in terms of species, group or to complex level with
the SYBR green mediated real time multiplex, PCR assay,
keeping 16S rRNA gene sequencing as the gold standard.
The PCR assay indicated the presence of two MTB iso-
lates and 23 NTM isolates in the collected bronchial
washings. However 16S rRNA gene sequencing confirmed
that one of the isolate was belonging to the genus Rhodo-
coccus which was positive in ZN stain. 16S amplicons
from two NTM positive cultures failed to yield DNA se-
quence data and as such further identification of these
two isolates could not be made. When mycobacterial cul-
ture was considered as the gold standard there were 26
isolates (17.3 %) belonging to the Mycobacterium genus
and among theses 23 (15.3 %) were NTM.
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In the past two decades, nucleic acid amplification-
based techniques such as PCR have become accessible to
the clinical mycobacteriology laboratory. Sequence based
methods are more rapid and accurate than the conven-
tional identification methods. Most PCR protocols have
concentrated on the detection of pathogenic MTB as they
claim more human lives than any other bacteria. Both in
house and commercial PCRs have been widely evaluated
[1, 2, 10, 19]. Real-time PCR techniques, involving fluores-
cent dyes or fluorophores with a spectrofluorometric
Fig. 1 a SYBR green mediated real-time PCR melting curve, Tm 77.10 °C, 81.50 °C and 85.06 °C indicating the presence of MTC, genus Mycobacterium
and MAC following Reaction I. b SYBR green mediated real-time PCR melting curve, Tm 80.70 °C and 84.90 °C indicating the presence of
genus Mycobacterium and MFG following Reaction II
Table 2 Effect of clarithromycin, amikacin and ciprofloxacin on the identified NTM isolates
SI number Isolate Organism Drug
Clarithromycin Amikacin Ciprofloxacin
1. KCC 142 Mycobacterium sp. (KU198858) R S S
2. KCC 06 PL Mycobacterium chelonae-abscessus complex (KU179046) S S R
3. KCC 124 Mycobacterium chelonae-abscessus complex (KU195328) S S R
4. KCC 06 RC Mycobacterium chelonae-abscessus complex (KU195330) R S R
5. KCC119 Mycobacterium celatum (KU179047) S S R
6. KCC 02 YC Rhodococcus sp. (KU198859) R S S
7. KCC 72 Mycobacterium sp.(KU195326) R S R
8. KCC 82 Mycobacterium sp.(KU195322) R S S
9. KCC 131 Mycobacterium avium complex(KU198858) R S S
10. KCC 94 Mycobacterium sp.(KU377301) R S S
11. KCC 98 Mycobacterium sp.(KU195324) R S S
12. KCC 90 Mycobacterium intracellulare (KU195323) S S S
13. KCC 101 Mycobacterium sp.(KU195327) R S S
14. KCC 78 Mycobacterium sp.(KU195320) R S R
15. KCC 83 Mycobacterium sp. (KU377300) R S S
16. KCC 129 Mycobacterium sp.(KU195325) R S S
17. KCC 76 Mycobacterium intracellulare (KU195319) R S S
18. KCC 81 Mycobacterium sp.(KU195321) R S S
19. KCC 97 Mycobacterium sp. (KU377299) R S S
20. KCC 59 Mycobacterium sp. (KU195318) R S S
21. KCC 132 Mycobacterium sp. R S S
22. KCC 73 Mycobacterium sp. R S R
R = resistant S = sensitive
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thermal cycler, have been used to develop a number of
rapid and sensitive assays for identification of bacteria and
viruses [20]. Several fluorescence formats are available for
the detection of amplified DNA of MTB. Most of these
assays have used SYBR Green, a double-stranded DNA
(dsDNA) binding dye that fluoresces when bound to
dsDNA [21]. Fluorimeter-based analysis also has pro-
vided a rapid and sensitive method for identification of
PCR products [21]. However, even species specific real-
time PCR, have their limitations since it only recognises
selected species of interest.
The molecular identification procedure which was elu-
cidated in this study intended to identify rapid and slow
growing mycobacteria in two separate reactions. Hence
this assay was able to differentiate the pathogenic myco-
bacterial presence with the use of these two parallel re-
actions. Including the Mycobacterium genus specific
primer set in both reactions was to use it as a positive
internal control which facilitated the identification of the
presence of various Mycobacterium species, though the
absence of the targeted organisms. A third of the world
population is thought to be infected with TB [21]. The
developing countries including Sri Lanka, are still suffer-
ing from TB, mainly due to poverty (lack of healthy liv-
ing conditions) and satisfactory medical care [22]. There
were two M. tuberculosis strains identified during the
study, both the strains were sensitive for the first line
anti TB drugs indicating that those were treatable tuber-
culosis cases. DNA from the identified M. tuberculosis
isolates were amplified, sequenced and deposited on to
the GenBank data base with the accession numbers
KU179045 and KU195329.
In this study a considerable proportion of the isolates
were identified as NTM. These were identified as slen-
der pink rods upon ZN staining which is still used as the
preliminary diagnostic tool in most of the developing
countries mainly due to the cost effectiveness and easy
performance [23]. The mycobacterial infections due to
these organisms might present similar clinical symptoms
mimicking TB, making the infection misdiagnosed as
TB, hence therapy would include anti-tuberculous drugs.
Precise identification of the Mycobacterium species be-
fore treatment can have a considerable influence on clin-
ical management. Misdiagnosis of NTM bacilli as MTB
and thereby considering it as pulmonary TB, can lead to
unnecessary treatment of patients which could lead to
the emergence of drug resistant Mycobacterium strains.
Moreover, Rhodococcus spp which was identified is also
an acid fast bacterium [24] which renders it difficult to
discriminate from MTB and NTM. Therefore molecular
identification methods are beneficial in the identification
of such species prior to initiation of treatment.
There are incidences where M. celatum isolates had
been isolated from bronchial washings [25] which was
elucidated as a potential human pathogen [26]. M. cela-
tum was first reported in 1993. This bacterium causes
pulmonary infections similar to the infections caused by
MTB and other NTM [19]. Even though, it was believed
that this organism causes infection in patients who have
depressed immunity there were reports describing pulmon-
ary infections caused by M. celatum in immuno-competent
patients [27]. The isolate from this study produced smooth,
convex, non-pigmented colonies on L-J medium. Even
though this species is known as a slow grower, the M.
celatum isolate identified (KU179047) during this study
was found to be rapidly growing bacterium which formed
colonies on L-J medium in less than 7 days. The isolate
was resistant to ciprofloxacin.
M. avium, M. intracellulare, M. chelonae, M. abscessus
and M. fortuitum are the most common NTM pathogens
found to be causing pulmonary infections [4]. Infections
caused by MAC (M. avium and M. intracellulare) could
lead to respiratory failure if untreated [28]. Increase in in-
cidence of MAC was reported in early 1980’s simultan-
eously with the beginning of the AIDS widespread [29].
Though the two species, M. avium and M. intracellulare
belong to a same group, in their pathogenicity and biology
they show significant differences [30]. During this study
three isolates were identified as MAC by multiplex Real-
time PCR assay, but when sequenced, two isolates were
confirmed as M. intracellulare and the other as M. avium.
The M. avium isolate (KU198857) and one of the M.
intracellulare isolates (KU195319) were resistant to the
drug clarithromycin while the other M.intracellulare iso-
late (KU195323) was sensitive to all the tested drugs.
Infections caused by MCAG consisting of rapidly
growing mycobacteria are a serious public health
problem. MCAG consists of M. immunogenum, M.
massiliense, M. bolletii, and M. salmoniphilum apart
from M. abscessus and M. chelonae [10]. These species
cannot be differentiated by biochemical testing and
their 16S rRNA gene sequences are often similar,
which renders it difficult to discriminate them indi-
vidually. There were three MCAG isolates (KU179046,
KU195328, and KU195330) identified during this study in
which two isolates were resistant to ciprofloxacin while
the other was resistant to both the clarithromycin and
ciprofloxacin.
In most of the developing countries AFB positive
smear microscopy is the tool to initiate anti TB treat-
ment. However before the availability of the culture re-
ports patients clinical conditions may deteriorate due
to many factors such as side effects of anti TB therapy,
drug resistance or if suffering from an infection due to
NTM. Thus the results of this described molecular
assay can help to expedite the decision making process
so that relevant treatment could be initiated without
delay.
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Conclusion
In conclusion, the optimized SYBR green mediated multi-
plex real time PCR procedure described, is rapid and
simple to perform and could assist in identifying and
differentiation of pathogenic M. tuberculosis complex
from the opportunistic non tuberculous mycobacteria,
which will allow early initiation of treatment depending
on the causative agent.
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